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MaBACKGROUND It is unclear what level of moderate to vigorous intensity physical activity (MVPA) offsets the health
risks of sitting.
OBJECTIVES The purpose of this study was to examine the joint and stratiﬁed associations of sitting and MVPA with
all-cause and cardiovascular disease (CVD) mortality, and to estimate the theoretical effect of replacing sitting time with
physical activity, standing, and sleep.
METHODS A longitudinal analysis of the 45 and Up Study calculated the multivariable-adjusted hazard ratios (HRs) of
sitting for each sitting-MVPA combination group and within MVPA strata. Isotemporal substitution modeling estimated
the per-hour HR effects of replacing sitting.
RESULTS A total of 8,689 deaths (1,644 due to CVD) occurred among 149,077 participants over an 8.9-year (median)
follow-up. There was a statistically signiﬁcant interaction between sitting and MVPA only for all-cause mortality. Sitting
time was associated with both mortality outcomes in a nearly dose-response manner in the least active groups
reporting <150 MVPA min/week. For example, among those reporting no MVPA, the all-cause mortality HR comparing
the most sedentary (>8 h/day) to the least sedentary (<4 h/day) groups was 1.52 (95% conﬁdence interval: 1.13 to 2.03).
There was inconsistent and weak evidence for elevated CVD and all-cause mortality risks with more sitting among those
meeting the lower (150 to 299 MVPA min/week) or upper ($300 MVPA min/week) limits of the MVPA recommendation.
Replacing sitting with walking and MVPA showed stronger associations among high sitters (>6 sitting h/day) where, for
example, the per-hour CVD mortality HR for sitting replaced with vigorous activity was 0.36 (95% conﬁdence interval:
0.17 to 0.74).
CONCLUSIONS Sitting is associated with all-cause and CVD mortality risk among the least physically active adults;
moderate-to-vigorous physical activity doses equivalent to meeting the current recommendations attenuate or
effectively eliminate such associations. (J Am Coll Cardiol 2019;73:2062–72) © 2019 The Authors. Published byElsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).N 0735-1097 https://doi.org/10.1016/j.jacc.2019.02.031
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AB BR E V I A T I O N S
AND ACRONYM S
CVD = cardiovascular disease
HR = hazard ratio
ISM = isotemporal substitution
modelling
MET = metabolic equivalents
MPA = moderate intensity
physical activity
MVPA = moderate to vigorous
physical activity
SB = sedentary behavior
VPA = vigorous intensity
physical activity
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2063P hysical activity has established protective ef-fects on health, and its potential beneﬁtsspan across the prevention, management,
and treatment of cardiovascular disease (CVD) (1).
Sedentary behavior (SB) represents the lowest end
of the physical activity spectrum and is commonly
deﬁned as a low energy expenditure of <1.5 metabolic
equivalents (MET) in a sitting or reclining posture
during waking hours (2). The links among SB, mortal-
ity, and cardiovascular disease are not always well
understood (3,4). For example, a meta-analysis of 9
prospective studies reported a nonlinear association
between sitting time and CVD events with increased
risk appearing at >10 h of sitting/day when physical
activity was taken into account (5). A large individual
participant pooled analysis that examined the joint
associations of sitting and physical activity (6) found
that the association between sitting and all-cause and
CVD mortality risk was gradually attenuated with
increased physical activity, to the point that it was
effectively nulliﬁed at amounts equivalent to >60 to
75 min of moderate-intensity physical activity a day.
Neither of these studies considered that a 24-h day
is ﬁnite, and an increase in any type of physical activ-
ity or SB would displace another activity or sleep.SEE PAGE 2073Evidence-based guidelines are the cornerstone of
public health and clinical practice (7). Understanding
the joint associations and the health-enhancing po-
tential of various physical activity alternatives to
sitting is important for the development of such
guidelines. Due to the absence of such evidence, SB
guidelines are currently nonspeciﬁc and are not al-
ways evidence-based (4,8). Considering the paucity of
randomized controlled trials with mortality and other
hard endpoints in the broader ﬁeld of physical activity
research (9), well-designed observational longitudinal
studies provide the best available evidence for public
health guidelines development (4). The recent 2018
U.S. Physical Activity Guidelines Advisory Committee
Scientiﬁc Report identiﬁed the paucity of prospective
studies on the interactive effects of physical activity
and sedentary behavior on all-cause and CVD mortal-
ity as a major evidence gap (10,11).
The main aim of this study was to examine the joint
associations of sitting and physical activity with all-
cause and CVD mortality in a large population sample
of middle-age and older Australian adults. An exten-
sion of this aim was to examine the associations be-
tween sitting andmortality separately in each physical
activity stratum. The secondary aim was to estimate
the theoretical effects of replacing sitting with stand-
ing, physical activity, and sleep on mortality risk.METHODS
SAMPLE. The analyses are based on data
from the 45 and Up Study (12), in which par-
ticipants completed a baseline questionnaire
from January 2006 through December 2009.
The 45 and Up Study is a large-scale
(N ¼ 267,119) prospective cohort of men and
women age 45 years or older living in the
state of New South Wales, Australia. Partici-
pants were randomly sampled from the
Department of Human Services enrollment
database. Eligible individuals were asked to
complete and mail the questionnaire and
consent forms to the study center. The 45 and
Up Study received ethics approval from the Univer-
sity of NSW Human Research Ethics Committee.
Approval to use data from the 45 and Up Study for
this paper was obtained from the NSW Population and
Health Services Ethics Committee (reference 2010/05/
234).
EXPOSURE VARIABLES. The sitting, standing, and
sleeping variables were assessed using the question
“About how many hours in each 24-h day do you
usually spend doing the following?” (13,14). The re-
sponses to these questions were recorded as h/day.
Such questions are in line with the sitting questions
in the International Physical Activity Questionnaire,
which have shown acceptable validity against accel-
erometry (coefﬁcients ranging between 0.33 to 0.34)
(15). Total weekly time for walking for recreation or
exercise, moderate intensity physical activity (MPA),
and vigorous physical activity (VPA) was assessed
using the Active Australia Survey questions: “If you
add up all the time you spent doing each activity last
week, how much time did you spend altogether doing
each type of activity?” For MPA and VPA, there was
additional explanation to deﬁne what each intensity
means (e.g., “that made you breathe harder or puff
and pant,.” for VPA) as well as examples of common
activities. These questions have been shown to have
acceptable reliability (coefﬁcients between 0.56 to
0.64) and validity (coefﬁcient of 0.52) (16,17).
POTENTIAL CONFOUNDERS. Potential confounders
were similar to previous 45 and Up Study SB analyses
(13,14): sex, age (5-year bands), educational level (12
years of school or less, >12 years of school), marital
status (married or de facto, single/divorced/sepa-
rated/widowed), urban/rural residence, body mass
index (BMI) (calculated as self-reported weight/[self-
reported height squared]), smoking status (current/
previous/never smoker), self-rated health (poor/fair/
good/very good/excellent), help with daily tasks,
FIGURE 1 Participant Sample Flowchart
45 and Up Baseline
Data (as of April 2018)
 
n = 266,699
Linked: 45 and Up – CVD
Deaths and Incidence
 
n = 266,699
Working Dataset
 
n = 218,933
Core Analytic Dataset
 
n = 149,077
Data Exclusions
•  All time use variables missing (n = 5,003)
•  At least 1 time use variable reported as 0 (n = 12,151)
•  All physical activity time use variables were missing (n = 3,579)
•  Total time >28 h (n = 26)
•  Total time <12 h (n = 9,844)
•  Total physical activity time > total standing time (n = 17,163)
Health and Missing Covariate Exclusions
•  CVD history at baseline (n = 37,501)
•  Cancer history at baseline (n = 34,999)
•  Missing fruit and vegetable information (n = 7,796)
CVD Outcome File
(linked to RBDM records)
 
n = 266,699
The departure sample of n ¼ 266,699 corresponds to the sampled 45 and Up Study respondents who returned the postal survey.
CVD ¼ cardiovascular disease; RBDM ¼ Registry of Births, Deaths, and Marriages.
Stamatakis et al. J A C C V O L . 7 3 , N O . 1 6 , 2 0 1 9
Sitting, Physical Activity, and Mortality Risk A P R I L 3 0 , 2 0 1 9 : 2 0 6 2 – 7 2
2064psychological distress (Kessler 10 scale [18]), servings
of fruit and vegetables per day (19), and previous
physician diagnoses of diabetes mellitus.
OUTCOME ASCERTAINMENT. All-cause mortality to
June 2017 was ascertained from the New South Wales
Registry of Births, Deaths, and Marriages. CVD related
mortality to December 2015 was ascertained from the
Cause of Death Unit Record File held by the Ministry
of Health. Linkage to of the 45 and Up Study to the
above databases was undertaken by the Centre for
Health Record Linkage (CHeReL). Classiﬁcation of a
CVD-related death was based on a ICD codes I00 to
I99, as deﬁned earlier (20).
DATA HANDLING. A detailed account of data clean-
ing, handling, and preparatory statistical testing
procedures is described elsewhere (Additional File 1
in Stamatakis et al. [14]). In summary, we used mul-
tiple imputation and the Expectation-Maximisation
algorithm (30 imputations) (21) to impute missing
data for participants who had at least 1 of the time use
behavioral variables missing. The multiple imputa-
tion model included age, sex, and nonmissing time
use variables as covariates. We examined the missingat random assumption of sitting variables, and no
apparent violations were noted. For the joint and
stratiﬁed analyses, daily sitting time categorization
was the same as in recent studies (6,22): <4, 4 to <6, 6
to 8, and >8 h. Weekly MVPA was categorized into no
physical activity (inactive), 1 to 149 min (insufﬁ-
ciently active), 150 to 299 min (sufﬁciently active at
the lower Australian physical activity recommenda-
tions limit) (23), 300 to 419 min (sufﬁciently active at
the upper limit) (23), and $420 min (corresponding to
roughly 35.5 MET-h/week, previously identiﬁed as
the threshold that eliminates mortality risks of sitting
[6,22]).
To satisfy the isotemporal substitution modelling
(ISM) assumption of linearity between independent
and dependent variables (14), we treated sleeping as a
piecewise variable with a breakpoint at 7 h (#7 and
>7 h/day). For the same reason, we treated sitting
time as a piecewise variable with a breakpoint at 6 h.
This 6-h/day cutpoint coincides with the recently
identiﬁed minimum sitting threshold for raised CVD
death risk (24). As per standard practice in epidemi-
ological studies (25), for the calculation of total MVPA
volume, each minute of VPA counted as 2 min of
TABLE 1 Distribution of Demographic, Behavioral, and Health Status Factors of the 45 and Up Participants by Amount of Time Spent Sitting Daily (n ¼ 149,077)
Category Total* 0-6 h Sitting >6 h Sitting 0-4 h Sitting 4-6 h Sitting 6-8 h Sitting 8þ h Sitting
Sex Female 82,695 (55.5) 62,848 (57.0) 18,323 (50.2) 27,374 (58.4) 24,303 (56.6) 21,975 (53.5) 7,519 (47.5)
Age group, yrs <60 87,371 (58.6) 61,377 (55.7) 24,618 (67.4) 27,787 (59.3) 22,535 (52.5) 24,169 (58.9) 11,504 (72.6)
Education status Degree or higher 40,282 (27.3) 26,484 (24.3) 13,230 (36.6) 10,569 (22.8) 10,291 (24.3) 12,575 (30.9) 6,279 (40.0)
Marital status Married/de facto 116,608 (78.6) 86,704 (79.1) 28,101 (77.3) 37,270 (80.0) 33,609 (78.7) 31,827 (77.9) 12,099 (76.7)
Employment status Work in some capacity 93,043 (62.6) 64,593 (58.8) 26,895 (73.8) 28,867 (61.8) 23,931 (56.0) 26,059 (63.6) 12,631 (79.9)
Remoteness Major cities 77,728 (53.2) 54,424 (50.4) 22,038 (61.5) 22,314 (48.6) 21,283 (50.5) 22,863 (56.7) 10,002 (64.3)
BMI category Obese 29,908 (21.5) 21,061 (20.5) 8,339 (24.2) 8,426 (19.3) 8,346 (20.9) 8,868 (23.0) 3,760 (25.1)
MVPA category, min 0 6,707 (4.5) 4,621 (4.2) 1,909 (5.2) 1,976 (4.2) 1,779 (4.1) 1,854 (4.5) 921 (5.8)
<150 23,604 (15.8) 16,339 (14.8) 6,846 (18.8) 6,687 (14.3) 6,433 (15.0) 6,799 (16.6) 3,266 (20.6)
150–299 24,576 (16.5) 17,046 (15.5) 7,144 (19.6) 7,017 (15.0) 6,678 (15.6) 7,151 (17.4) 3,344 (21.1)
300–420 17,835 (12.0) 12,673 (11.5) 4,884 (13.4) 5,192 (11.1) 4,896 (11.4) 5,308 (12.9) 2,161 (13.6)
>420 76,355 (51.2) 59,498 (54.0) 15,722 (43.1) 25,978 (55.4) 23,145 (53.9) 19,943 (48.6) 6,154 (38.8)
Smoking status Never smoked 87,565 (58.7) 64,733 (58.8) 21,401 (58.6) 27,980 (59.7) 25,110 (58.5) 23,684 (57.7) 9,360 (59.1)
Self-rated health Excellent 27,676 (18.8) 20,731 (19.1) 6,498 (18.0) 9,500 (20.6) 7,631 (18.0) 7,316 (18.0) 2,782 (17.7)
Needs help with a disability 4,029 (2.8) 2,733 (2.5) 1,238 (3.5) 995 (2.2) 1,115 (2.7) 1,258 (3.1) 603 (3.9)
Physician-diagnosed diabetes
(self-report)
9,798 (6.6) 7,138 (6.5) 2,502 (6.9) 2,758 (5.9) 2,899 (6.8) 2,888 (7.0) 1,095 (6.9)
Psychological distress:
K10 category score
High (scores 22–50) 9,438 (6.8) 6,699 (6.5) 2,578 (7.4) 2,945 (6.8) 2,468 (6.2) 2,629 (6.8) 1,235 (8.1)
Values are n (%). *2,384 participants had missing sitting time data.
BMI ¼ body mass index.
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2065MPA. Missing covariates data ranged from 0.4%
(employment status) to 6.5% (BMI). For the core
analyses, we adopted a missing indicator approach
for all categorical covariates, which involved creating
a dummy category to denote missingness.
STATISTICAL ANALYSES. Analyses were performed
using SAS software version 9.3 (SAS Institute Inc.,
Cary, North Carolina). The association between
sitting and risk of mortality was analyzed using Cox
proportional hazards regression models with survival
time (in years) as the time from baseline to death or
the censor point. We examined the joint association
between physical activity and sitting by deriving a
combined variable with 20 groups (6), where the
combined lowest sitting (<4 h/day) and highest MVPA
($420 min/week) served as the reference category.
We also ran Cox models of sitting and mortality
within each physical activity stratum in a similar
fashion to the recent pooled analysis (22). Effect
modiﬁcation was tested by ﬁtting an interaction term
between sitting and MVPA groups. To reduce the
possibility of spurious associations due to reverse
causation, we repeated all analyses after excluding all
participants who died from any cause (n ¼ 835) or
CVD causes (n ¼ 241) in the ﬁrst 24 months of follow-
up. In another set of sensitivity analyses, we repeated
all models in the sample that had valid data in all
covariates (n ¼ 123,031).
We estimated the classical partition model which
generate estimates of changes in risk/h of sittingincrease, which assumes that the exposure is added
to the daily time rather than substituting another
activity (14,26). The partition model is the standard
type of Cox analysis that has been used in the vast
majority of epidemiological studies in the ﬁeld. The
ISM analyses make a more realistic assumption that
an increase in one behavior will be accompanied by a
decrease of equal duration (isotemporal) in another
behavior while total time in all behaviors is kept
constant. For example, to estimate the effect of
substituting 1 h of sitting with walking, walking is
removed from a model adjusted for all individual
behavior components (sleep, MPA, standing, and so
on) as well as total time spent in all activities (14,26).
Sitting was modelled in 1-h intervals in both sitting
groups (#6 and >6 h/day). Although nondomain-
speciﬁc screen time was included in the ISM
analyses, we did not report its replacement effect
estimates due to the limited clinical value of such
information.
RESULTS
A total of 218,913 participants were initially consid-
ered, after excluding those with an invalid date of
recruitment and implausible covariate or exposure
variable values (n ¼ 47,975) (Figure 1). Following
further exclusions of 63,735 participants who had
heart disease, stroke, or cancer at baseline and 6,121
participants who had missing fruit and vegetable
CENTRAL ILLUSTRATION Joint Associations of Sitting and Physical Activity Time and All-Cause Mortality Events
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Stamatakis, E. et al. J Am Coll Cardiol. 2019;73(16):2062–72.
Multivariable-adjusted analysis; n ¼ 149,077, n events ¼ 8,689. Adjusted for age, sex, education, marital status, remoteness, body mass index, smoking, self-rated
health, help for disability, psychological distress, fruit and vegetable consumption, and diabetes. CI ¼ conﬁdence interval.
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2066consumption information, the core analytic sample
size was 149,077. The median follow-up for all-cause
mortality was 8.9 years, corresponding to 1,355,574
person-years and 8,689 deaths, and for CVD mortality
was 7.4 years, corresponding to 1,144,279 person-
years and 1,644 deaths. Table 1 presents the charac-
teristics of the core analytic sample by sitting times.
Online Table 1 presents the reported mean daily times
of sedentary behavior, physical activity, and sleep by
sitting time groups. Online Figure 1 presents the
splines describing the overall curves of sitting and
physical activity variables with CVD mortality.
JOINT AND STRATIFIED ASSOCIATIONS OF SITTING
AND PHYSICAL ACTIVITY WITH MORTALITY RISK.
Online Table 2 presents the events count and sample
size across categories of the joint sitting-MVPA vari-
able. The sitting  MVPA group interaction test in
both the imputed and unimputed models wasstatistically signiﬁcant for ACM (p < 0.001) but not for
CVD mortality (imputed model p ¼ 0.478).
In both the joint and stratiﬁed analyses, with a
few exceptions, sitting was mostly associated with
the mortality outcomes among the least physically
active groups only. In the joint MVPA-sitting ana-
lyses, combinations of higher sitting time and lower
MVPA were deleteriously associated with ACM risk in
the physically inactive and insufﬁciently active
groups (Central Illustration). Across groups that met
any physical activity recommendation, only sitting
for >8 h/day and meeting the lower physical activity
recommendation was associated with increased risk
(hazard ratio [HR]: 1.27; 95% conﬁdence interval [CI]:
1.08 to 1.50). For CVD mortality, there was a dose
response with higher sitting and lower MVPA among
the inactive and insufﬁciently active groups
(Figure 2). Among those meeting the lower physical
FIGURE 2 The Joint Associations of Sitting and Physical Activity Time and Cardiovascular Disease Mortality Events
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Multivariable-adjusted analysis n ¼ 149,077, n events ¼ 1,644. Adjusted for age, sex, education, marital status, remoteness, body mass index, smoking, self-rated
health, help for disability, psychological distress, fruit and vegetable consumption, and diabetes. CI ¼ conﬁdence interval.
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2067activity recommendation, all sitting groups had
elevated risk (for example, HR: 1.45; 95% CI: 1.12 to
1.88 for the 4 to 6 h/day sitting group), although
there was no evidence for a dose-response (Figure 2).
The results of the analyses stratiﬁed by MVPA group
were in broad agreement with the joint analyses:
associations between sitting and ACM (Figure 3) and
CVD mortality risk (Figure 4) were largely limited to
the 2 least active groups. Unlike the joint analyses,
however, sitting was not associated with elevated
CVD mortality risk among those meeting the lower
physical activity recommendation. The detailed data
used in Online Figures 2 to 13 are presented in Online
Tables 3 to 14. Removing events occurring in the ﬁrst
24 months of follow-up did not appreciably change
the joint or stratiﬁed associations (Online Figures 2
to 5). Repeating analyses in the unimputed dataset
of participants who had valid data for all covariates
(n ¼ 123,031; 6,161 ACM events; 1,077 CVD mortality
events) led to some attenuation of the associations
(in both magnitude and gradient) across several
sitting-MVPA combinations (Online Figures 6 and 7)
and strata of MVPA (Online Figures 8 and 9). For
example, the HR for ACM for those who met thelower physical activity recommendation and re-
ported sitting for >8 h/day was attenuated to 1.18
(95% CI: 0.98 to 1.42). No appreciable differences
were observed when those who died in the ﬁrst
24 months of follow-up were excluded (Online
Figures 10 to 13). Across all main and sensitivity
joint analyses, the combination of highly active
(>420 MVPA min/week) and 6 to 8 h sitting/day
tended to point toward increased CVD mortality risk,
although it did not reach statistical signiﬁcance.
REPLACEMENT EFFECTS OF SITTING TIME WITH
PHYSICAL ACTIVITY, STANDING, AND SLEEP.
Tables 2 and 3 present the multivariable-adjusted per-
hour estimates of ACM and CVD risk stratiﬁed by low
(#6 h/day) and high (>6 h/day) sitting level. In the
partition models, each additional hour of daily sitting
was associated with increased ACM risk among high
sitters only (HR: 1.04; 95% CI: 1.02 to 1.06) (Table 2).
Replacing sitting with standing was associated with a
small reduction in ACM risk among low sitters only
(HR: 0.97; 95% CI: 0.96 to 0.99). Replacing sitting
with walking and VPA (but not with MPA) was asso-
ciated with ACM risk reduction, in particular among
FIGURE 3 The Stratiﬁed Associations of Sitting and All-Cause Mortality Events Within Each Physical Activity Category
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Multivariable-adjusted analysis n ¼ 149,077, n events ¼ 8,689. Adjusted for age, sex, education, marital status, remoteness, body mass index, smoking,
self-rated health, help for disability, psychological distress, fruit and vegetable consumption, and diabetes. CI ¼ conﬁdence interval.
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of sitting for walking was 0.78 (95% CI: 0.70 to 0.87).
There was little evidence for replacement effects of
sitting with sleeping on ACM mortality among low
sleepers (#7 h/day); in contrast, there were relatively
large increases in ACM risk (7% to 14%/h) when sitting
was replaced with sleeping in high sleepers (>7 h/
day).
Each additional hour of daily sitting was associated
with increased CVD death risk among high sitters only
(HR: 1.07; 95% CI: 1.03 to 1.12) (Table 3). Replacing
sitting with standing was associated with a reduction
in CVD risk among low sitters only (HR: 0.94; 95% CI:
0.91 to 0.98). Replacing sitting with MPA and VPA
(but not walking) was associated with lower CVD
mortality risk in both sitting groups, although the
replacement effects were more pronounced among
high sitters (HR: 0.80; 95% CI: 0.70 to 0.93 for MPA;
HR: 0.36; 95% CI: 0.17 to 0.74 for VPA). The CVD
mortality ISM estimates for replacing sitting with
sleeping were broadly comparable to the equivalent
ACM mortality estimates described in the previous
text.
Removing deaths occurring in the ﬁrst 24 months
of follow-up, repeating analyses in the sample with
valid data in all covariates, or imputing BMI valueshad no material impact on the partition and ISM es-
timates (Online Tables 15 to 19).
DISCUSSION
This is the ﬁrst study on sitting and mortality risk to
use a comprehensive analytic approach involving
joint MVPA-sitting effects, stratiﬁcation by MVPA,
and replacement effects. We found that higher sitting
times were associated with higher ACM and CVD
mortality risk, but these associations were in most
cases restricted to those not meeting the physical
activity recommendations (Central Illustration).
Compared with the lowest risk category of the
joint analysis of 20 mutually exclusive categories
(>420 min of MVPA and <4 h of sitting/day), the
gradient of the sitting-ACM and -CVD associations
progressively leveled off with higher levels of phys-
ical activity (Central Illustration, Figure 2). Meeting
even the lower 150 to 299 min/week physical activity
recommendation eliminated the association of
sitting with ACM risk, where estimates only in the
top sitting category (>8 h/day) reached statistical
signiﬁcance. Our results support continued efforts to
promote physical activity in those segments of the
population that are physically inactive. Lower daily
FIGURE 4 The Stratiﬁed Associations of Sitting and Cardiovascular Disease Mortality Events Within Each Physical Activity Category
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Multivariable-adjusted analysis n ¼ 149,077, n events ¼ 1,644. Adjusted for age, sex, education, marital status, remoteness, body mass index, smoking, self-rated
health, help for disability, psychological distress, fruit and vegetable consumption, and diabetes. CI ¼ conﬁdence interval.
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2069sitting time reduced the risk among those who re-
ported >8 h of sitting/day, although risks remained
substantially elevated compared with the reference
group, who were highly active and sat for <4 h/day
(e.g., 60% and 44% higher risk in the groups
with <4 h of sitting who were physically inactive and
insufﬁciently active, respectively). Such ﬁndings
suggest that in the absence of some physical activity,
reducing sitting times may be insufﬁcient for optimal
health beneﬁt.
Several prospective studies have found that the
associations of sitting time with fatal or nonfatal
CVD risk are dependent on MVPA levels (27–29).
Although our interaction test was not statistically
signiﬁcant for CVD death, our results in their to-
tality are broadly consistent with recent large joint
(6) and stratiﬁed (22) analyses of sitting and ACM
(6) and CVD (6,22) mortality. In both studies, which
arose from the same pooled harmonized dataset, a
dose-response association between sitting time and
ACM and CVD mortality was observed in the lowest
quartiles of physical activity (<2.5 MET-h/week)
where, for example, CVD mortality was 32% higher in
those who sat for >8 h/day compared with the lowestsitting group (<4 h/day) (22). Although the associa-
tions of sitting with both mortality outcomes was less
consistent across the other physical activity strata,
clearer evidence for elimination of the sitting effects
was seen in the most active group (>35.5 MET-h/week)
(4), which is roughly equivalent to $420 min. Our re-
sults differ in that adherence to the lower physical
activity limit (150 to 299 min/week) largely offset the
increased risk of sitting except in those who reported
very high sitting time, while adherence to the
upper limit of at least 300 min/week eliminated
the associations. Our ﬁndings offer support for this
unique ”upper limit” aspect of the 2014 Australian
and, more recently, the 2018 U.S. (11) physical activity
guidelines.
The modeled effects of sitting on mortality risk
varied considerably by sitting level: replacing sitting
with standing was associated with risk reduction in
low sitters, but replacing sitting with physical ac-
tivity had more consistent protective associations in
high sitters (Tables 2 and 3). These ﬁndings corrob-
orate the outcomes from 2 nonisotemporal meta-
analyses that showed nonlinear association
between sedentary time and risk of CVD events only
TABLE 2 Independent* and Replacement Effects of Sitting With Physical Activity, Sleeping on ACM Mortality
1. Isotemporal
Substitution Model†
Replace 1 h of:
With 1 h of:
2. Partition Model
(HR and 95% CI
per h of sitting)*
A. Sleeping
(#7 h)
B. Sleeping
(#7 h) C. Standing D. Walking E. MPA F. VPA
All samples‡ Sitting (#6 h) 1.01 (1.00–1.02) 1.07 (1.05–1.10) 0.97 (0.96–0.99) 0.97 (0.94–1.02) 0.99 (0.97–1.02) 0.92 (0.86–1.00) 1.01 (0.99–1.02)
Sitting (>6 h) 1.00 (0.98–1.01) 1.14 (1.08–1.20) 0.98 (0.95–1.01) 0.78 (0.70–0.87) 0.97 (0.92–1.02) 0.69 (0.56–0.88) 1.04 (1.02–1.06)
Values are hazard ratio (95% conﬁdence interval). Imputed data n ¼ 149,077, n events ¼ 8,689. *Adjusted for sex, age, educational level, marital status, urban or rural residence, body mass index, smoking
status, self-rated health, fruit and vegetable consumption receiving help with daily tasks for a long-term illness or disability, prevalent diabetes at baseline, and psychological distress, and mutually adjusted
for all activity classes. †Adjusted for sex, age, educational level, marital status, urban or rural residence, body mass index, smoking status, self-rated health, total fruit and vegetable consumption, receiving
help with daily tasks for a long-term illness or disability, psychological distress, mutually adjusted for all activity classes, and total time in all activities classes. ‡Multiple imputation was used to replace
missing time of the activity classes (based on age, sex, and non-missing other activity classes variables).
TABLE 3 Independe
1. Isote
Substituti
Replace
All Sample‡ Sitting
Sitting
Imputed data n ¼ 149,077
consumption receiving help
educational level, marital s
disability, psychological dis
nonmissing other activity c
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2070among those who reported sitting for >6 h/day (24)
or 10 h/day (5). In our study, sitting level appeared
to modify the magnitude of the associations when
we modeled the effects of replacing sitting with
standing and physical activity. For example, replac-
ing 1 h of sitting with 1 h of standing was associated
with 3% (ACM) and 6% (CVD) reduction in low sit-
ters, but there was no such association in high sit-
ters. While there is no biologically apparent
explanation for this ﬁnding, it is noteworthy that
low sitters reported almost double the standing (5.7
h/day vs. 3.1 h/day) compared with high sitters. Such
large differences between the two sitting groups may
reﬂect that standing is a proxy of ambulatory light
intensity physical activity (30). Another possible
explanation is that among the most sedentary
groups replacing sitting with standing may not be
sufﬁcient for reducing health risks. In such groups
substituting sitting for walking (which was associ-
ated with 10% to 12% reduction in mortality risk)
may be a better option that is feasible for the ma-
jority of adults. We noted inconsistent replacement
effects for substituting sitting for MPA, which
showed clear associations only among high sitters
(20% reduction in CVD mortality per replaced hour).
The largest replacement effects were observed for
VPA, for example, 31% (ACM) and 64% (CVD) risk
reduction per hour replaced in high sitters (Tables 2
and 3). Although our ﬁndings are supported bynt* and Replacement Effects of Sitting With Physical Activity, Sleeping o
mporal
on Model†
1 h of:
With 1 h of:
A. Sleeping
(#7 h)
B. Sleeping
(#7 h) C. Standing D.
(#6 h) 1.03 (1.00–1.05) 1.09 (1.03–1.15) 0.94 (0.91–0.98) 1.06
(>6 h) 0.99 (0.95–1.03) 1.10 (0.99–1.22) 0.97 (0.92–1.03) 0.90
, n events ¼ 1,644. *Adjusted for sex, age, educational level, marital status, urban or rura
with daily tasks for a long-term illness or disability, prevalent diabetes at baseline, psycho
tatus, urban or rural residence, body mass index, smoking status, self-rated health, total frui
tress, mutually adjusted for all activity classes, and total time in all activities classes. ‡Mult
lasses variables).previous work showing that that participation in
VPA maximizes the population beneﬁts of physical
activity (25), translation into tangible health mes-
sages for CVD and premature mortality prevention
may be challenging. VPA, as reported in the 45 and
Up Study, consisted mainly of exercise and sports, a
class of physical activity that may not be immedi-
ately accessible to sedentary middle-age and older
people who are not accustomed to physical exertion;
and who may need to be supervised during exercise.
Replacing sitting with sleeping showed no clear
associations with mortality risk in those sleeping
#7 h/day and, like previously (14), deleterious asso-
ciations in those sleeping >7 h/day. Our results
contrast previous cross-sectional results with surro-
gate CVD outcomes, suggesting that replacing
sedentary behavior with sleep is associated with
favorable cardiometabolic proﬁles (31), although we
acknowledge that interpretation of our ﬁndings is less
straightforward due to the necessitated dichotomi-
zation of sleep and sitting variables.
An immediate implication of an independent
biological mechanism for sitting would be a risk
gradient by increasing sitting time across all MVPA
groups. Although our study did not address biolog-
ical mechanisms, both our ﬁndings and the data
summarized in the previous text (4,22,27,29) offer
little support to the 2016 Science Advisory from the
American Heart Association report (3), whichn CVD Mortality
2. Partition Model
(HR and 95% CI
per h of Sitting)*Walking E. MPA F. VPA
(0.97–1.16) 0.95 (0.89–1.01) 0.72 (0.56–0.91) 1.02 (0.99–1.04)
(0.73–1.12) 0.80 (0.70–0.93) 0.36 (0.17–0.74) 1.07 (1.03–1.12)
l residence, body mass index, smoking status, self-rated health, fruit and vegetable
logical distress, and mutually adjusted for all activity classes. †Adjusted for sex, age,
t and vegetable consumption, receiving help with daily tasks for a long-term illness or
iple imputation to replace missing time of the activity classes (based on age, sex, and
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Among relatively inactive middle-aged people, the
amount of time spent sitting is associated with
increased risks of both cardiovascular and all-cause
mortality.
TRANSLATIONAL OUTLOOK: Future research
should seek to deﬁne optimum physical activity
regimens to prevent cardiovascular events and
premature mortality among those who spend large
amounts of time sitting.
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2071concluded that SB inﬂuences cardiometabolic health
in part independent of MVPA. Our ﬁndings also
contrast the conclusions of a recent meta-analysis
that reported an increased CVD hazard of 1% to
2%/h of sitting time “independent” of physical ac-
tivity (24). Studies included in this review assessed
independence by merely statistically adjusting for
MVPA, an approach that is insufﬁcient on its own, as
it ignores evidence of effect modiﬁcation
(6,22,27,29).
STUDY STRENGTHS AND LIMITATIONS. The strengths of
our study include one of largest population-based
studies to date, our comprehensive statistical
approach, the multiple measures we took to account
for reverse causation, and the sitting level–speciﬁc
ISM structure that revealed novel insights into
possible differential replacement effects. In com-
parison to the recent larger pooled harmonized
studies of similar scope (6,22), our study has several
advantages, including the consistent measurements
used and the individual-level analyses. A limitation
of our work was that the exposures were only
measured at baseline and our data did not reﬂect
complete time-use as we lacked information on
light-intensity physical activity (ambulatory activ-
ities 1.5 to 3 MET). Our ISM results are based on
statistical modeling and not on actual replacements.
The ISM approach is regression-based and could not
handle complete 24-h data due to the unavoidable
collinearity. Although we were able to adjust ana-
lyses for several key confounders, we cannot rule
out the presence of unmeasured confounding. For
example, we could not adjust for biomedical risk
factors such as cholesterol and blood pressure,
although these variables are less likely to be con-
founders and more likely to be on the intermediate
causal pathway between physical activity, sitting,
and mortality. While the 45 and Up Study response
rate was relatively low (18% [12]), it is unlikely that
our results were materially compromised as relative
risks based on internal comparisons are not depen-
dent on representativeness (32). A previous analysis
that compared a broad range of exposure-outcome
associations in the 45 and Up Study with another
New South Wales population study with much
higher response rate (w60%) found that the relative
risk estimates in the 2 studies were almost identical
in magnitude and direction (33). Although the pub-
lished validity coefﬁcients of the sitting measure-
ment used in 45 and Up Study are of moderate
strength (15), they are in line with the estimates of
other self-report sitting questionnaires (34). Sitting
and MVPA exposures were self-reported and aretherefore likely prone to measurement error.
Depending on the nature of such error in exposures
and covariates (random vs. systematic), the reported
estimates may be biased towards or away from the
null. Assuming that the measurement error is
random our results may under-estimate the true
associations of sitting and mortality risk. Conversely,
such measurement error in the effect modiﬁer
(MVPA) may have diminished effect modiﬁcation
and have made it harder to identify groups at higher
risk.
CONCLUSIONS
Our comprehensive joint and stratiﬁed analyses on
sitting, physical activity and mortality risk found
that higher amounts of physical activity effectively
eliminated the association of sitting time with ACM
and CVD mortality risk. Replacing sitting with
walking and VPA is associated with the most
consistent risk reductions. Reduction of sitting time
is an important strategy, ancillary to increasing
physical activity, for preventing cardiovascular dis-
ease and premature mortality in physically inactive
populations.
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